Hepatitis C Diagnosis and Treatment Options: A Patient's Guide - Gastroenterology and Hepatology

Share to:

How to diagnose Hepatitis C?


My father visited your hospital due to abdominal pain and discomfort.
Blood tests revealed he has Hepatitis C, with GOT at 120 and GPT at 150.
An abdominal ultrasound was performed, and he was prescribed medication.
On November 11, his GOT decreased to 60 and GPT to 55.
The doctor suggested considering a liver biopsy if treatment is needed, but there has been no blood test to check the viral load.
How can we determine if the doctor's diagnosis is incorrect, and is a liver biopsy truly necessary? Why would the doctor make such a recommendation, especially since the biopsy is suggested after a period of treatment? Please clarify my doubts.
Thank you.

Yilan Xiao Hushi, 20~29 year old female. Ask Date: 2003/11/11

Dr. Zhang Yuting reply Gastroenterology and Hepatology


Currently, the diagnosis of hepatitis C is performed using serological tests, which measure whether the patient has antibodies against the hepatitis C virus (anti-HCV antibodies).
However, patients who test positive for antibodies do not necessarily have protective immunity, nor does this test indicate the viral load in their body.
To confirm viral infection and determine the viral load, an HCV RNA test is required; however, this test is not covered by health insurance and must be paid for out-of-pocket by the patient.
As a result, most general practitioners do not typically request this test for their patients.

The current standard treatment for hepatitis C involves a combination therapy of interferon and ribavirin, which is not effective for 100% of patients and may cause side effects.
Additionally, in the past, health insurance did not cover treatment costs, so unless a patient had good financial means and a high willingness to undergo treatment, many doctors opted for conservative management through observation.

Recently, the National Health Insurance Administration has initiated a pilot program for hepatitis C treatment, willing to cover the costs of treatment, but one of the requirements is that a liver biopsy must be performed.
Therefore, if your father wishes to receive interferon treatment with coverage from the health insurance, he will need to undergo a liver biopsy.
Since each hepatitis C patient has a unique condition, the appropriate treatment approach may vary.
If you have questions, it is best to consult with a physician in an outpatient setting to discuss your father's specific situation in detail for the best guidance.

Reply Date: 2003/11/11

More Info


Understanding Hepatitis C Diagnosis and Treatment Options: A Patient's Guide
Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation and potential long-term complications such as cirrhosis and liver cancer. The diagnosis and management of Hepatitis C can be complex, and it is understandable that you have questions regarding your father's situation.
From your description, your father was diagnosed with Hepatitis C after experiencing abdominal pain and elevated liver enzymes (GOT and GPT). The initial tests indicated significant liver inflammation, as evidenced by the elevated levels of these enzymes. Following treatment, there was a notable improvement in liver enzyme levels, which is a positive sign. However, the decision to perform a liver biopsy (or liver puncture) is often a point of contention among patients and healthcare providers.


Why Consider a Liver Biopsy?
A liver biopsy is a procedure that involves taking a small sample of liver tissue to assess the extent of liver damage, inflammation, and fibrosis (scarring). The results can provide critical information about the severity of the disease and help guide treatment decisions. Here are some reasons why your father's doctor might recommend a biopsy:
1. Assessment of Liver Damage: The biopsy can determine the degree of fibrosis or cirrhosis, which is crucial for deciding on the urgency and type of treatment. Patients with significant fibrosis may require more aggressive treatment.

2. Treatment Eligibility: In many healthcare systems, including some in the U.S., a liver biopsy is often required to qualify for certain treatments, especially if they are costly or involve significant side effects. This is particularly true for interferon-based therapies, which have specific eligibility criteria.

3. Monitoring Disease Progression: A biopsy can help establish a baseline for monitoring the disease over time. If your father’s liver condition worsens, it may necessitate a change in treatment strategy.


Why Not Perform a Biopsy Immediately?
It is not uncommon for doctors to delay a biopsy until after initial treatment has been attempted. This approach can be based on several factors:
1. Initial Response to Treatment: If the liver enzymes improve significantly with initial treatment, the doctor may decide to monitor the situation rather than perform an invasive procedure. This can reduce unnecessary risks and costs.

2. Cost and Insurance Considerations: In some cases, patients may need to cover the cost of a biopsy out-of-pocket if it is not deemed medically necessary by insurance providers. This can lead to a more conservative approach initially.

3. Clinical Guidelines: Many clinicians follow specific guidelines that recommend starting treatment based on liver enzyme levels and clinical symptoms, reserving biopsy for cases where the response to treatment is unclear or if there are concerns about the severity of liver disease.


Understanding the Need for Viral Load Testing
You mentioned that your father has not undergone testing for the viral load (HCV RNA). This test is crucial for understanding the extent of the infection and determining the most appropriate treatment. Here’s why:
1. Determining Infectiousness: The viral load test measures the amount of virus in the blood, which can help assess how contagious your father might be.

2. Guiding Treatment Decisions: Knowing the viral load can help determine the likelihood of treatment success and inform the choice of antiviral medications.

3. Monitoring Treatment Efficacy: After starting treatment, regular viral load testing can help assess how well the treatment is working and whether adjustments are needed.


Conclusion
In summary, while a liver biopsy can provide valuable information about the extent of liver damage and guide treatment decisions, it is not always immediately necessary, especially if there is a positive response to initial treatment. The decision to perform a biopsy should be made collaboratively between your father and his healthcare provider, considering all relevant factors, including liver enzyme levels, viral load, and overall health status.

It is essential to maintain open communication with the healthcare team. If you have concerns about the diagnosis or treatment plan, consider scheduling a follow-up appointment to discuss these issues in detail. Understanding the rationale behind each step in the diagnostic and treatment process can help alleviate some of the uncertainties you may be feeling.

Similar Q&A

Navigating Hepatitis C Treatment: Options, Costs, and Lifestyle Considerations

Hello, doctors. I have been suffering from liver disease for a long time. Five years ago, a blood test revealed that I had both hepatitis B and C viruses. A month later, I went to a Christian hospital for further testing, and it confirmed only hepatitis C. Since then, I have been...


Dr. Yang Peizhen reply Gastroenterology and Hepatology
Hello! First of all, it must be emphasized that hepatitis C is transmitted through blood and bodily fluids, and is fundamentally unrelated to diet. Chronic hepatitis C has a high rate of viral mutation, which makes treatment outcomes less than ideal. Currently, the most effective...

[Read More] Navigating Hepatitis C Treatment: Options, Costs, and Lifestyle Considerations


Understanding Chronic Hepatitis C: Treatment Options and Definition

Chronic hepatitis C treatment methods include antiviral medications such as direct-acting antivirals (DAAs), which are highly effective in curing the infection. Treatment regimens typically last from 8 to 12 weeks, depending on the specific medication used and the patient's ...


Dr. Chen Jingwen reply Internal Medicine
After infection with the hepatitis C virus, there is an 80-90% chance of developing chronic hepatitis. After 20 years, 20% of those with chronic hepatitis may progress to cirrhosis, and among cirrhosis patients, there is an annual incidence of 3-6% for hepatocellular carcinoma. C...

[Read More] Understanding Chronic Hepatitis C: Treatment Options and Definition


Effective Treatment and Prevention Strategies for Hepatitis C

If it is known that one has hepatitis C, how should it be treated and what measures can be taken to prevent it from progressing to chronic hepatitis?


Dr. Chen Jingwen reply Internal Medicine
Infection with hepatitis C can lead to chronic hepatitis in about half of the cases. These individuals have a risk of developing cirrhosis or liver cancer after several years. Therefore, once diagnosed with chronic hepatitis C, it is essential to monitor liver function (GOT, GPT)...

[Read More] Effective Treatment and Prevention Strategies for Hepatitis C


Understanding Hepatitis C: Diagnosis, Treatment, and Transmission Risks

Your girlfriend recently tested positive for Hepatitis C. Here are the answers to your questions: 1. Next Steps for Testing and Treatment: Your girlfriend should consult a hepatologist or a specialist in infectious diseases for further evaluation. The next steps typically in...


Dr. Chen Shidian reply Gastroenterology and Hepatology
Dear Mr. A-Wei, I recommend checking the detailed information on the "Liver Disease Prevention and Treatment Academic Foundation" at National Taiwan University. Generally, active treatment is recommended when liver function is consistently above 80 (according to health...

[Read More] Understanding Hepatitis C: Diagnosis, Treatment, and Transmission Risks


Related FAQ

Hepatitis C

(Gastroenterology and Hepatology)

Hepatitis

(Gastroenterology and Hepatology)

Hepatitis C Infection Risk

(Gastroenterology and Hepatology)

Cholecystitis

(Gastroenterology and Hepatology)

Liver Fibrosis

(Gastroenterology and Hepatology)

Hepatitis B Medication

(Gastroenterology and Hepatology)

Hepatitis C

(Internal Medicine)

Hepatitis B Screening

(Gastroenterology and Hepatology)

Blood

(Gastroenterology and Hepatology)

Total Bilirubin

(Gastroenterology and Hepatology)